Position in LEGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$249,407
New position
Shares Held
8,636
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#154
of 217 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Granite Investment Partners, LLC holds $85,167,773 across 14 Biotechnology names. LEGN ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
80,124 | $19,611,951 | |
| 2 | LGND |
Ligand Pharmaceuticals Inc
|
54,128 | $17,109,319 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
172,228 | $14,975,224 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
32,837 | $12,204,527 | |
| 5 | TECH |
BIO-TECHNE Corp
|
133,572 | $9,436,861 | |
| 6 | VCEL |
Vericel Corp
|
121,696 | $5,414,255 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
63,598 | $4,977,815 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
5,026 | $398,511 |
All Filings in LEGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $249,407 | 8,636 | Shares | Sole | 2026-08-07 | |
| No filing history on record for this holder in this stock. | ||||||